Company Overview of CovX Research LLC
CovX Research LLC, a biotechnology company, engages in the discovery and development of long-acting biological therapies called CovX-Bodies. Its products pipeline focuses on targets that inhibit tumor angiogenesis and modulate metabolic disorders. Its products pipeline includes CVX-045, a thrombospondin-1 mimetic CovX-Body; TSP-1, a negative regulator of angiogenesis that acts as a therapeutic target in oncology; CVX-060, a selective angiopoietin-2 antagonist COVX-BODY; and CVX-096, a long-acting GLP-1 mimetic COVX-BODY. The company was founded in 2002 and is based in San Diego, California. As of January 2008, CovX Research LLC operates as a subsidiary of Pfizer Inc.
9381 Judicial Drive
San Diego, CA 92121
Founded in 2002
Key Executives for CovX Research LLC
Similar Private Companies By Industry
|Specialized Vascular Technologies, Inc.||United States|
|UroVention, LLC||United States|
|Nomocan Pharmaceuticals LLC||United States|
|CoStim Pharmaceuticals Inc.||United States|
|Newco Tech, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact CovX Research LLC, please visit www.covx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.